| 94090-8 |
Views for dialysis fistula^W contrast IA & Guidance for percutaneous transluminal angioplasty + transcatheter placement of stent |
Find |
XXX>Vessels |
Pt |
Doc |
RF.angio |
|
ACTIVE |
RFA Views for dialysis fistula W contrast IA and Guidance for percutaneous transluminal angioplasty transcatheter placement of stent |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
94090-8 |
|
RF.angio |
|
|
Observation |
|
|
|
0 |
RFA dial fist W c IA + PTA + stent place |
|
|
|
|
|
Arteriogram; c; Contr; Contra; Contrst; D fist^W c+G p tran ang + trn p stnt; Dialy; Document; Films; Finding; Findings; Fis^W c IA & prc trns ang + stent plc; Fistulogram; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Perc; Point in time; PTA; RADIOLOGY; Random; RFA; Spec; To be specified in another part of the message; Unspecified; Vesl; Vessels.XXX; View; Vs dial fist^W c IA & Perc trans angio; Vs dial fistula^W cont IA; Vs for dial fistula; VWS; W c IA & Perc Trans Angio; W c IA + PTA + stent place; W contr IA; WC |
2.72 |
2.67 |
|
|
|
|
|
|
|
|
|
|
Release 2.72: DefinitionDescription: Replaced "TBA" with appropriate LOINC code.; |
0 |
| 94091-6 |
Views for dialysis fistula^W contrast IA & Guidance for percutaneous transluminal angioplasty |
Find |
XXX>Vessels |
Pt |
Doc |
RF.angio |
|
ACTIVE |
RFA Views for dialysis fistula W contrast IA and Guidance for percutaneous transluminal angioplasty |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
94091-6 |
|
RF.angio |
|
|
Both |
|
|
|
0 |
RFA dial fist W c IA + PTA |
|
|
|
|
|
Arteriogram; c; Contr; Contra; Contrst; Dialy; Document; Films; Finding; Findings; Fistulogram; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Perc; Point in time; PTA; RADIOLOGY; Random; RFA; Spec; To be specified in another part of the message; Unspecified; Vesl; Vessels.XXX; View; Vs dial fist^W c IA & Perc trans angio; Vs dial fistula^W cont IA; Vs for dial fistula; VWS; W c IA & Perc Trans Angio; W contr IA; WC |
2.72 |
2.67 |
|
|
|
|
|
|
|
|
|
|
Release 2.72: DefinitionDescription: Replaced "TBA" with appropriate LOINC code.; |
0 |
| 94092-4 |
Views for dialysis fistula^W contrast IA |
Find |
XXX>Vessels |
Pt |
Doc |
RF.angio |
|
ACTIVE |
RFA Views for dialysis fistula W contrast IA |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
94092-4 |
|
RF.angio |
|
|
Observation |
|
|
|
0 |
RFA Vs for dial fistula W contr IA |
|
|
|
|
|
Arteriogram; c; Contr; Contra; Contrst; Dialy; Document; Films; Finding; Findings; Fistulogram; Fluor; Fluoro; Fluoroscopy; Imaging; Misc; Miscellaneous; Other; Point in time; Radiology; Random; RFA; Spec; To be specified in another part of the message; Unspecified; Vesl; Vessels.XXX; View; Vs dial fistula^W cont IA; Vs for dial fistula; VWS; W contr IA; WC |
2.72 |
2.67 |
|
|
|
|
|
|
|
|
|
|
Release 2.72: DefinitionDescription: Replaced "TBA" with appropriate LOINC codes.; |
0 |
| 94093-2 |
Itemized bill |
Find |
^Patient |
Pt |
Doc |
|
|
ACTIVE |
Itemized bill |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.MISC |
|
94093-2 |
|
|
|
|
Both |
|
|
|
0 |
Itemized bill |
|
|
|
|
|
DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random |
2.67 |
2.67 |
Y |
|
|
|
|
|
|
|
|
|
|
0 |
| 94094-0 |
Views limited for therapy or embolization or infusion^W contrast via existing catheter |
Find |
XXX |
Pt |
Doc |
RF.angio |
|
ACTIVE |
RFA Unspecified body region Limited Views for therapy or embolization or infusion W contrast via existing catheter |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
94094-0 |
|
RF.angio |
|
|
Both |
|
|
|
0 |
RFA Vs Ltd W contr via exist cath |
|
|
|
|
|
c; Cath; Contr; Contra; Contrst; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; LMTED; LTD; LVs thpy or emb or inf^W c v ex cath; Misc; Miscellaneous; Other; Point in time; Radiology; Random; RFA; Spec; To be specified in another part of the message; Unspecified; View; Views Ltd; Vs Ltd; VWS; W contr via exist cath; WC |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 94095-7 |
Views^W contrast IV |
Find |
Extremity.unilateral>Extremity vessels |
Pt |
Doc |
RF.angio |
|
ACTIVE |
RFA Extremity vessels Unilateral Views W contrast IV |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
RAD |
|
94095-7 |
|
RF.angio |
|
|
Both |
|
|
|
0 |
RFA Ext ves-Ul Views W contr IV |
|
|
|
|
|
c; Contr; Contra; Contrst; Document; EXT; Ext ves-Ul; Extr ves; Extr-Ul; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Point in time; Radiology; Random; RFA; Vesl; Vessels.XXX; View; VWS; W contr IV; WC |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 94096-5 |
Collagen type VII Ab.IgG |
PrThr |
Ser/Plas |
Pt |
Ord |
IA |
|
ACTIVE |
Collagen type VII IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
94096-5 |
|
IA |
|
|
Observation |
|
|
|
0 |
CollagenVII IgG SerPl Ql IA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; COL7; Collagen type 7; Collagen VII Ab; CollagenVII; EIA; ELFA; ELISA; Enzyme immunoassay; Epidermolysis bullosa acquisita; IAA; Immune globulin G; Immunoglobulin G; MEIA; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 94097-3 |
Cytosolic 5'-nucleotidase 1A Ab.IgG |
PrThr |
Ser/Plas |
Pt |
Ord |
IA |
|
ACTIVE |
Cytosolic 5'-nucleotidase 1A IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
94097-3 |
|
IA |
|
|
Both |
|
|
|
0 |
cN-1A IgG SerPl Ql IA |
|
|
|
|
|
5NT; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; cN1A; cN-1A; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; Inclusion body myositis; Inclusion Body Myositis, Sporadic; MEIA; Mup44; NT; NT5C1A; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 94098-1 |
Dense fine speckled 70 protein Ab.IgG |
PrThr |
Ser/Plas |
Pt |
Ord |
IA |
|
ACTIVE |
Dense fine speckled 70 protein IgG Ab [Presence] in Serum or Plasma by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
94098-1 |
|
IA |
|
|
Both |
|
|
|
0 |
DFS70 IgG SerPl Ql IA |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; DFS70; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Ordinal; Pl; Plasma; Plsm; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 94099-9 |
Hantavirus Ab.IgM |
PrThr |
Ser/Plas |
Pt |
Ord |
IF |
|
ACTIVE |
Hantavirus IgM Ab [Presence] in Serum or Plasma by Immunofluorescence |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
94099-9 |
|
IF |
|
|
Observation |
|
|
|
0 |
Hantavirus IgM SerPl Ql IF |
|
|
|
|
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Microbiology; Ordinal; Orthohantavirus; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR; Time Resolved Fluorescence; TRF |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 941-5 |
Bombay Ag |
PrThr |
RBC^Donor |
Pt |
Ord |
|
|
DEPRECATED |
Deprecated Bombay Ag [Presence] on Red Blood Cells from donor |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
941-5 |
|
|
|
|
Observation |
|
|
|
0 |
Deprecated Bombay Ag RBC Donr Ql |
|
|
|
|
|
Antigen; Antigens; BLOOD BANK; Donr; Erythrocytes; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.61 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 9410-2 |
Histamine |
MRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Histamine [Mass/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
ug/24 H |
|
|
|
|
|
|
CHEM |
|
9410-2 |
|
|
|
|
Both |
|
|
|
0 |
Histamine 24h Ur-mRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Chemistry; Mass rate; mRate; QNT; Quan; Quant; Quantitative; UA; UR; Urn |
2.73 |
1.0i |
|
|
|
|
|
|
|
ug/(24.h) |
|
|
|
0 |
| 94100-5 |
Hantavirus seoul Ab.IgM |
PrThr |
Ser/Plas |
Pt |
Ord |
Line blot |
|
ACTIVE |
Hantavirus seoul IgM Ab [Presence] in Serum or Plasma by Line blot |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
94100-5 |
|
Line blot |
|
|
Observation |
|
|
|
0 |
H seoul IgM SerPl Ql Line blot |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; H seoul; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; Immune globulin M; Immunoglobulin M; Microbiology; Ordinal; Orthohantavirus; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Seoul orthohantavirus; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 94101-3 |
Hantavirus seoul Ab.IgG |
PrThr |
Ser/Plas |
Pt |
Ord |
Line blot |
|
ACTIVE |
Hantavirus seoul IgG Ab [Presence] in Serum or Plasma by Line blot |
|
ADD |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
94101-3 |
|
Line blot |
|
|
Observation |
|
|
|
0 |
H seoul IgG SerPl Ql Line blot |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; H seoul; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; Immune globulin G; Immunoglobulin G; Microbiology; Ordinal; Orthohantavirus; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Seoul orthohantavirus; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 94102-1 |
Epstein Barr virus early diffuse Ab.IgA |
ACnc |
Ser/Plas |
Pt |
Qn |
IA |
|
ACTIVE |
Epstein Barr virus early diffuse IgA Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
ADD |
DefinitionDescription |
|
|
IU/mL |
|
|
|
|
|
|
MICRO |
|
94102-1 |
|
IA |
|
|
Both |
|
|
|
0 |
EBV EA-D IgA SerPl IA-aCnc |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EA; EA-D; EBV; EBV EA; EBV EA-D; EIA; ELFA; ELISA; Enzyme immunoassay; Epstn; HHV-4; human herpesvirus 4; IAA; Immune globulin A; Immunoglobulin A; MEIA; Microbiology; Mono; Mononucleosis; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS |
2.67 |
2.67 |
|
|
|
|
|
|
|
[IU]/mL |
|
|
|
0 |
| 94103-9 |
Zolpidem phenyl-4-carboxylate |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
Zolpidem phenyl-4-carboxylate [Presence] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
Qual |
|
|
|
|
|
|
DRUG/TOX |
|
94103-9 |
|
Screen |
|
|
Both |
|
|
|
0 |
Zolpidem phenyl-4-carb Ur Ql Scn |
|
|
|
|
|
Adormix; Ambien; Ambien CR; Damixan; DRUG/TOXICOLOGY; Drugs; Edluar; Hypnogen; Ivedal; Lioran; Myslee; Nasen; Nytamel; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Sanval; Scn; Scr; Screen; Scrn; Somidem; Stilnoct; Stilnox; Stilnox CR; Sucedal; UA; UR; Urn; Zoldem; Zolpihexal; Zolpimist |
2.73 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 94104-7 |
Zolpidem |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
Zolpidem [Presence] in Urine by Screen method |
|
ADD |
DefinitionDescription |
|
|
Qual |
|
|
|
|
|
|
DRUG/TOX |
|
94104-7 |
|
Screen |
|
|
Both |
|
|
|
0 |
Zolpidem Ur Ql Scn |
|
|
|
|
|
Addiction; Adormix; Ambien; Ambien CR; Damixan; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Edluar; Hypnogen; Illicit; Ivedal; Lioran; Myslee; Nasen; Nytamel; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sanval; Scn; Scr; Screen; Scrn; Somidem; Stilnoct; Stilnox; Stilnox CR; Sucedal; UA; UR; Urn; Zoldem; Zolpihexal; Zolpimist |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 94105-4 |
Alpha hydroxytriazolam |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
Alpha hydroxytriazolam [Presence] in Urine by Screen method |
|
ADD |
DefinitionDescription |
|
|
Qual |
|
|
|
|
|
|
DRUG/TOX |
|
94105-4 |
|
Screen |
|
|
Both |
|
|
|
0 |
A-OH-triazolam Ur Ql Scn |
|
|
|
|
|
1-hydroxytriazolam; Alfa; Alpha hydroxy triazolam; A-OH-triazolam; DRUG/TOXICOLOGY; Drugs; Hydroxy triazolam; OH-Triazolam; OHTRZ; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Triazolam metabolite; UA; UR; Urn |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 94106-2 |
Temazepam glucuronide |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
Temazepam glucuronide [Presence] in Urine by Screen method |
|
ADD |
DefinitionDescription |
|
|
Qual |
|
|
|
|
|
|
DRUG/TOX |
|
94106-2 |
|
Screen |
|
|
Both |
|
|
|
0 |
Temazepam glucuronide Ur Ql Scn |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; Gluc; Glucouronide; Normison; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Restoril; Scn; Scr; Screen; Scrn; UA; UR; Urn |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 94107-0 |
Oxazepam glucuronide |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
Oxazepam glucuronide [Presence] in Urine by Screen method |
|
ADD |
DefinitionDescription |
|
|
Qual |
|
|
|
|
|
|
DRUG/TOX |
|
94107-0 |
|
Screen |
|
|
Both |
|
|
|
0 |
Oxazepam glucuronide Ur Ql Scn |
|
|
|
|
|
Alepam; Chlordiazepoxide metabolite; Diazepam metabolite; DRUG/TOXICOLOGY; Drugs; Gluc; Glucouronide; Ordinal; Point in time; PR; Prazepam metabolite; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Serax; Temazepam metabolite; UA; UR; Urn |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 94108-8 |
1-Hydroxymidazolam |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
1-Hydroxymidazolam [Presence] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
Qual |
|
|
|
|
|
|
DRUG/TOX |
|
94108-8 |
|
Screen |
|
|
Both |
|
|
|
0 |
1OH-midazolam Ur Ql Scn |
|
|
|
|
|
1-Hydroxy midazolam; 1OH-midazolam; Alpha hydroxymidazolam; Alpha-hydroxymidazolam; Chlonazepam metabolite; DRUG/TOXICOLOGY; Drugs; i; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn |
2.73 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 94109-6 |
LORazepam glucuronide |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
LORazepam glucuronide [Presence] in Urine by Screen method |
|
ADD |
DefinitionDescription |
|
|
Qual |
|
|
|
|
|
|
DRUG/TOX |
|
94109-6 |
|
Screen |
|
|
Both |
|
|
|
0 |
LORazepam glucuronide Ur Ql Scn |
|
|
|
|
|
Ativan; DRUG/TOXICOLOGY; Drugs; Gluc; Glucouronide; Lorazepam metabolite; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 9411-0 |
Hydrocorticosterone |
MRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Hydrocorticosterone [Mass/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
mg/24 H |
|
|
|
|
|
|
CHEM |
|
9411-0 |
|
|
|
|
Both |
|
|
|
0 |
Hydrocorticostern 24h Ur-mRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Chemistry; Hydrocorticostern; Mass Rate; mRate; QNT; Quan; Quant; Quantitative; UA; UR; Urn |
2.42 |
1.0i |
|
|
|
|
|
|
|
mg/(24.h) |
|
|
|
0 |
| 94110-4 |
2-Hydroxyethylflurazepam |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
2-Hydroxyethylflurazepam [Presence] in Urine by Screen method |
|
ADD |
DefinitionDescription |
|
|
Qual |
|
|
|
|
|
|
DRUG/TOX |
|
94110-4 |
|
Screen |
|
|
Both |
|
|
|
0 |
2-OH-Ethylfluraz Ur Ql Scn |
|
|
|
|
|
2-OH-Ethylfluraz; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; Hydroxy ethylflurazepam; II; OH-Ethylfluraz; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 94111-2 |
7-Aminoflunitrazepam |
PrThr |
Urine |
Pt |
Ord |
Screen |
|
ACTIVE |
7-Aminoflunitrazepam [Presence] in Urine by Screen method |
|
ADD |
DefinitionDescription |
|
|
Qual |
|
|
|
|
|
|
DRUG/TOX |
|
94111-2 |
|
Screen |
|
|
Both |
|
|
|
0 |
7Aminoflunitrazepam Ur Ql Scn |
|
|
|
|
|
7-amino flunitrazepam; 7Aminoflunitrazepam; DRUG/TOXICOLOGY; Drugs; Flunitrazepam metabolite; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn |
2.67 |
2.67 |
|
|
|
|
|
|
|
|
|
|
|
0 |
